Stockchase Opinions

David Burrows PDL BioPharma PDLI-Q DON'T BUY Jul 12, 2006

Higher valuation stocks are going to have a tougher time when people are concerned about a slowing economy. This one has been weakening since March. There is no sign of any real bounce on the little bit of recent strength.
$17.800

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
Company is developing compounds which won't harm the body but will help. Multi-billion dollar business. He has owned it for about 3 months and continues to buy.